China's H1N1 Flu Vaccine Said To Pass Phase I Trials
This article was originally published in PharmAsia News
Executive Summary
The Health Ministry in China declared its version of an H1N1 flu vaccine has passed Phase I trials showing it to be safe and efficacious. The vaccine already is being prepared for Phase II trials after the initial round turned up no severe adverse reactions among more than 13,000 volunteers. Health Minister Chen Zhu held a news conference to announce the results and received his second injection of the vaccine. (Click here for more